Mukherjee et al. compared ovarian (OVCA) and breast (MCF-7) cancer cell lines stimulated with estrogen, demonstrating that EOC cells are characterized by an ER-dependent downregulation of PRG expression that can be reverted through ER antagonists [46]. The gene discussed is ESR1; the disease is cancer.